Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emricasan in Severe Alcoholic Hepatitis
NCT01912404Phase 2Terminated
- Sponsor
- Conatus Pharmaceuticals Inc.
- Start
- Jul 2013
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emricasan in alcoholic hepatitis (AH), sponsored by Conatus Pharmaceuticals Inc.. Started Jul 2013; status: terminated.
02
Drugs
emricasan
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT01912404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01912404.